Paul studied for a PhD in Quantum Physics at King’s College London and after a spell in the City working for a variety of top-tier investment banks as a quantitative analyst, he returned to scientific research at the University of Oxford.
An accomplished author and writer of numerous scientific articles on cancer research in world-class peer reviewed journals, Paul is also involved in several companies devoted to new cancer screening and diagnostic technology in breast cancer.
Paul is currently Visiting Professor at the Sigmund Freud University, Vienna, Austria researching new imaging techniques for detecting breast cancer.
Prof. Paul Darbyshire
With over 30 years’ of New Product Sales, Project Management and Account Management experience, Robert has demonstrable success tightly managing various multi-sector projects, working closely with clients to ensure their requirements are delivered on time and within budget.
Robert is also the CEO of Enmgima Ltd.; a company specialising in new breast cancer imaging technologies. He is responsible for liaising with key companies to further advance Enmgima's technology and engage with new partners to develop the world's-first non-invasive breast cancer device.
With a wealth of experience spanning more than 30 years in various business, account management and marketing roles, Lisa’s key responsibilities have been to manage and implement the Marketing and Communications Strategy for both B2B and B2C target audiences. She has also managed various CRM and CMS systems, ensuring controlled management of customer information and external facing web and social media platforms for the commercial, private and voluntary sectors.